12:00 AM
 | 
Jan 07, 2013
 |  BC Week In Review  |  Company News  |  Deals

RaQualia, Eli Lilly deal

On Dec. 20, 2012, RaQualia said it extended a December 2010 deal with Eli Lilly to identify and develop compounds against undisclosed ion channel targets...

Read the full 101 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >